By becoming a member, you can learn about current best practices, engage with industry leaders, collaborate with fellow DTx companies, participate in member events, and help shape the DTx industry by contributing your expertise.
You can also join us for regional membership meetings, add your voice to drive the clinical, organizational, and financial integration of digital therapeutics, and work with policymakers to create pathways for healthcare equity.
Don’t miss this opportunity to distinguish your company and have access to the constantly evolving landscape of the DTx industry.
Membership Application
The Value of DTA Membership
Learn about current best practices and opportunities in digital therapeutics:
- Engage with industry leaders. Collaborate with fellow DTx industry and engage with other leading companies dedicated to the manufacture, evaluation, and distribution of digital therapeutics.
- Participate in member events. Join member-only forums, social events, and roundtable discussions.
Collaborate with industry partners to advance digital therapeutics adoption:
- Join Work Groups. Help shape the DTx industry by contributing your expertise as we advance the Alliance’s priority issues and initiatives.
- Attend DTA Membership Meetings. Join us multiple times a year for regional gatherings hosted remotely (and eventually in-person).
Distinguish your company:
- Be an Industry Leader. Add your voice as we drive the clinical, organizational, and financial integration of digital therapeutics into mainstream healthcare.
- Develop Policy. Work with policymakers and fellow industry associations to help create solutions for challenging issues facing the global healthcare industry.
- Design Industry Frameworks. Directly engage in the design of the industry’s founding principles, best practices, and regulatory/coverage pathways. Access growing repositories of industry knowledge and insights.
“DTA’s the leader and go-to resource for all things digital therapeutics worldwide. By promoting the understanding, adoption, and integration of clinically evaluated digital therapeutics, DTA is critical in advancing this industry and making these innovative treatments more widely accessible. This aligns perfectly with our mission at WELT.”
Danny Jooyoung Kim, Head of WELT USA